Superficial Basal Cell Carcinoma

Also known as: Superficial basal cell carcinoma (disorder) / Superficial basal cell carcinoma (morphologic abnormality) / Basal cell carcinoma / Carcinoma basal cell / Basalioma / Basal cell epithelioma / Rodent ulcer / Basal cell carcinoma (morphologic abnormality) / Basal cell carcinoma of skin (disorder) / Carcinoma, Basal Cell

DrugDrug NameDrug Description
DB00544FluorouracilA pyrimidine analog used to treat basal cell carcinomas, and as an injection in palliative cancer treatment.
DB00724ImiquimodA toll-like receptor 7 agonist used to treat non hyperkeratotic, non hypertrophic actinic keratosis, basal cell carcinoma, genital or perianal warts, and condyloma acuminata.
DrugDrug NamePhaseStatusCount
DB09270Ubidecarenone1 / 2Completed1
DB05013Ingenol mebutate2Completed2
DB06137Tirbanibulin2Recruiting1
DB02300Calcipotriol2 / 3Recruiting1
DB00544Fluorouracil2 / 3Recruiting1
DB00855Aminolevulinic acid3Active Not Recruiting1
DB00724Imiquimod3Completed1
DB00855Aminolevulinic acid4Unknown Status1
DB00992Methyl aminolevulinate4Unknown Status1
DB00668EpinephrineNot AvailableCompleted1
DB00281LidocaineNot AvailableCompleted1
DB00992Methyl aminolevulinateNot AvailableCompleted1